BIOMAT Database Logo BIOMAT Database Logo

Regulation of glycophorin of complement activation via the alternative pathway. 1982

N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003170 Complement Pathway, Alternative Complement activation initiated by the interaction of microbial ANTIGENS with COMPLEMENT C3B. When COMPLEMENT FACTOR B binds to the membrane-bound C3b, COMPLEMENT FACTOR D cleaves it to form alternative C3 CONVERTASE (C3BBB) which, stabilized by COMPLEMENT FACTOR P, is able to cleave multiple COMPLEMENT C3 to form alternative C5 CONVERTASE (C3BBB3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Alternative Complement Pathway,Properdin Pathway,Alternative Complement Activation Pathway,Complement Activation Pathway, Alternative
D006021 Glycophorins The major sialoglycoprotein of human erythrocyte membranes. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocyte Sialoglycoproteins,Glycoconnectin,Glycoconnectins,Glycophorin,Glycophorin D,MN Sialoglycoprotein,Red Blood Cell Membrane Sialoglycoprotein,Glycophorin A,Glycophorin A(M),Glycophorin B,Glycophorin C,Glycophorin E,Glycophorin HA,Ss Erythrocyte Membrane Sialoglycoproteins,Ss Sialoglycoprotein,beta-Sialoglycoprotein,Sialoglycoprotein, MN,Sialoglycoprotein, Ss,Sialoglycoproteins, Erythrocyte,beta Sialoglycoprotein
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012794 Sialic Acids A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues. N-Acetylneuraminic Acids,Acids, N-Acetylneuraminic,Acids, Sialic,N Acetylneuraminic Acids
D012795 Sialoglycoproteins Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. Polysialoglycoprotein,Sialoglycopeptide,Sialoglycopeptides,Sialoglycoprotein,Sialoprotein,Sialoproteins,Polysialoglycoproteins

Related Publications

N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Activation of complement via the alternative pathway.
January 1983, Federation proceedings,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
The alternative pathway of complement activation.
January 1976, Advances in immunology,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Activation of the alternative complement pathway.
November 1979, CRC Critical reviews in immunology,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Complement-mediated killing of Opisthorchis viverrini via activation of the alternative pathway.
August 1986, International journal for parasitology,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
The human alternative complement pathway: biology and immunopathology of activation and regulation.
January 1982, Progress in allergy,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Species-specific inhibition by glycophorins of complement activation via the alternative pathway.
November 1983, Molecular immunology,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina.
January 2016, PloS one,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.
November 2011, Microbiology and immunology,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
[Activation pathway of complement (classical, alternative, lectin)].
April 2005, Nihon rinsho. Japanese journal of clinical medicine,
N Okada, and T Yasuda, and T Tsumita, and H Shinomiya, and S Utsumi, and H Okada
Trichomonas vaginalis: alternative pathway activation of complement.
January 1982, Transactions of the Royal Society of Tropical Medicine and Hygiene,
Copied contents to your clipboard!